344 related articles for article (PubMed ID: 32122685)
1. The action of TH17 cells on blood brain barrier in multiple sclerosis and experimental autoimmune encephalomyelitis.
Balasa R; Barcutean L; Balasa A; Motataianu A; Roman-Filip C; Manu D
Hum Immunol; 2020 May; 81(5):237-243. PubMed ID: 32122685
[TBL] [Abstract][Full Text] [Related]
2. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination.
Rostami A; Ciric B
J Neurol Sci; 2013 Oct; 333(1-2):76-87. PubMed ID: 23578791
[TBL] [Abstract][Full Text] [Related]
3. Intercellular Adhesion Molecule-1 (ICAM-1) and ICAM-2 Differentially Contribute to Peripheral Activation and CNS Entry of Autoaggressive Th1 and Th17 Cells in Experimental Autoimmune Encephalomyelitis.
Haghayegh Jahromi N; Marchetti L; Moalli F; Duc D; Basso C; Tardent H; Kaba E; Deutsch U; Pot C; Sallusto F; Stein JV; Engelhardt B
Front Immunol; 2019; 10():3056. PubMed ID: 31993059
[TBL] [Abstract][Full Text] [Related]
4. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis.
Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH
J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618
[TBL] [Abstract][Full Text] [Related]
5. Caveolin1 Is Required for Th1 Cell Infiltration, but Not Tight Junction Remodeling, at the Blood-Brain Barrier in Autoimmune Neuroinflammation.
Lutz SE; Smith JR; Kim DH; Olson CVL; Ellefsen K; Bates JM; Gandhi SP; Agalliu D
Cell Rep; 2017 Nov; 21(8):2104-2117. PubMed ID: 29166603
[TBL] [Abstract][Full Text] [Related]
6. Th17 cell, the new player of neuroinflammatory process in multiple sclerosis.
Jadidi-Niaragh F; Mirshafiey A
Scand J Immunol; 2011 Jul; 74(1):1-13. PubMed ID: 21338381
[TBL] [Abstract][Full Text] [Related]
7. IKKβ-mediated inflammatory myeloid cell activation exacerbates experimental autoimmune encephalomyelitis by potentiating Th1/Th17 cell activation and compromising blood brain barrier.
Lee MJ; Bing SJ; Choi J; Jang M; Lee G; Lee H; Chang BS; Jee Y; Lee SJ; Cho IH
Mol Neurodegener; 2016 Jul; 11(1):54. PubMed ID: 27450563
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-26, preferentially produced by T
Broux B; Zandee S; Gowing E; Charabati M; Lécuyer MA; Tastet O; Hachehouche L; Bourbonnière L; Ouimet JP; Lemaitre F; Larouche S; Cayrol R; Bouthillier A; Moumdjian R; Lahav B; Poirier J; Duquette P; Arbour N; Peelen E; Prat A
Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32788322
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M triggers brain inflammation by compromising blood-brain barrier integrity.
Hermans D; Houben E; Baeten P; Slaets H; Janssens K; Hoeks C; Hosseinkhani B; Duran G; Bormans S; Gowing E; Hoornaert C; Beckers L; Fung WK; Schroten H; Ishikawa H; Fraussen J; Thoelen R; de Vries HE; Kooij G; Zandee S; Prat A; Hellings N; Broux B
Acta Neuropathol; 2022 Aug; 144(2):259-281. PubMed ID: 35666306
[TBL] [Abstract][Full Text] [Related]
10. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System.
Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B
Front Immunol; 2019; 10():2436. PubMed ID: 31681316
[TBL] [Abstract][Full Text] [Related]
11. Lack of junctional adhesion molecule (JAM)-B ameliorates experimental autoimmune encephalomyelitis.
Tietz S; Périnat T; Greene G; Enzmann G; Deutsch U; Adams R; Imhof B; Aurrand-Lions M; Engelhardt B
Brain Behav Immun; 2018 Oct; 73():3-20. PubMed ID: 29920328
[TBL] [Abstract][Full Text] [Related]
12. Adenosine A2A receptor agonist ameliorates EAE and correlates with Th1 cytokine-induced blood brain barrier dysfunction via suppression of MLCK signaling pathway.
Liu Y; Alahiri M; Ulloa B; Xie B; Sadiq SA
Immun Inflamm Dis; 2018 Mar; 6(1):72-80. PubMed ID: 29027376
[TBL] [Abstract][Full Text] [Related]
13. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
14. Focal disturbances in the blood-brain barrier are associated with formation of neuroinflammatory lesions.
Alvarez JI; Saint-Laurent O; Godschalk A; Terouz S; Briels C; Larouche S; Bourbonnière L; Larochelle C; Prat A
Neurobiol Dis; 2015 Feb; 74():14-24. PubMed ID: 25448765
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effect of baicalin on experimental autoimmune encephalomyelitis is mediated by SOCS3 regulatory pathway.
Zhang Y; Li X; Ciric B; Ma CG; Gran B; Rostami A; Zhang GX
Sci Rep; 2015 Nov; 5():17407. PubMed ID: 26616302
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated with multiple sclerosis and experimental autoimmune encephalomyelitis.
Zhang J; Cheng Y; Cui W; Li M; Li B; Guo L
J Neuroimmunol; 2014 Jan; 266(1-2):56-63. PubMed ID: 24332164
[TBL] [Abstract][Full Text] [Related]
17. Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells.
Nouri M; Bredberg A; Weström B; Lavasani S
PLoS One; 2014; 9(9):e106335. PubMed ID: 25184418
[TBL] [Abstract][Full Text] [Related]
18. Th Cell Diversity in Experimental Autoimmune Encephalomyelitis and Multiple Sclerosis.
Carbajal KS; Mironova Y; Ulrich-Lewis JT; Kulkarni D; Grifka-Walk HM; Huber AK; Shrager P; Giger RJ; Segal BM
J Immunol; 2015 Sep; 195(6):2552-9. PubMed ID: 26238492
[TBL] [Abstract][Full Text] [Related]
19. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis.
Shen R; Deng W; Li C; Zeng G
Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476
[TBL] [Abstract][Full Text] [Related]
20. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation.
Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W
Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
